Filter
856
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
89
New Publications
197
Language
Document type
No document type
362
Studies & Reports
194
Guidelines
159
Manuals
63
Strategic & Response Plan
44
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
43
India
28
Kenya
27
Nigeria
23
Western and Central Europe
22
Ethiopia
19
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Tanzania
10
Eastern Europe
10
Ghana
9
Philippines
9
Rwanda
9
Namibia
9
Latin America and the Carribbean
9
Zimbabwe
8
Malawi
8
Nepal
7
Africa
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
264
Clinical Guidelines
88
Public Health
44
Key Resources
40
Pharmacy & Technologies
36
Women & Child Health
29
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
105
COVID-19
61
TB
45
HIV
44
Mental Health
32
Rapid Response
29
NTDs
28
NCDs
19
Global Health Education
18
Planetary Health
18
Conflict
15
Malaria
14
2.0 Rapid Response
14
Caregiver
12
Health Financing Toolbox
12
Specific Hazards
7
Disability
6
Ebola & Marburg
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Revised Edition
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea
...
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39th Session of the Codex Alimentarius Commission (CAC) agreed it was important for the food safety comm
...
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to understand how change in WASH services and quality improvements have been implemented in Ethiopia at nati
...
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o
...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal
...
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a
...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w
...
Waste Management & Research 39(1) DOI: 10.1177/0734242X211029175
